Arteriography Coronary There is no relevant literature to support the use of coronary arteriography for the evaluation of HCM. Arteriography Coronary with Ventriculography There is no relevant literature to support the use of coronary arteriography with ventriculography for the evaluation of HCM. CT Chest There is no relevant literature to support the use of CT chest for the evaluation of HCM. CT Coronary Calcium There is no relevant literature to support the use of CT coronary calcium for the evaluation of HCM. CT Heart Function and Morphology Cardiac CT can be used in the evaluation of morphology and function in patients with suboptimal echocardiography. CT can provide accurate measurements of myocardial thickness. Myocardial fibrosis can be demonstrated and quantified in delayed-enhancement images with substantial agreement with MRI [36-38]. CTA Coronary There is no relevant literature to support the use of CTA in the evaluation of HCM when ischemic cardiomyopathy has already been excluded. FDG-PET/CT Heart There is no relevant literature to support the use of FDG-PET/CT heart for the evaluation of HCM. MRI Chest There is no relevant literature to support the use of MRI chest for the evaluation of HCM. MRI Heart Function and Morphology MRI provides comprehensive information for the evaluation of HCM, including the morphology, location, distribution, and extent of hypertrophy and fibrosis [39]. MRI is superior to echocardiography in recognizing areas of segmental hypertrophy, which may be missed or underestimated with echocardiography, particularly the LV apex, the RV anterior free wall, and the LV inferoseptum [39,40]. RV hypertrophy is seen in a third of Nonischemic Myocardial Disease patients [40]. MRI is more accurate than echocardiography in quantifying the myocardial thickness, which is an important prognostic indicator for myectomy [39].
Nonischemic Myocardial Disease with Clinical Manifestations Ischemic Cardiomyopathy Already Excluded . Arteriography Coronary There is no relevant literature to support the use of coronary arteriography for the evaluation of HCM. Arteriography Coronary with Ventriculography There is no relevant literature to support the use of coronary arteriography with ventriculography for the evaluation of HCM. CT Chest There is no relevant literature to support the use of CT chest for the evaluation of HCM. CT Coronary Calcium There is no relevant literature to support the use of CT coronary calcium for the evaluation of HCM. CT Heart Function and Morphology Cardiac CT can be used in the evaluation of morphology and function in patients with suboptimal echocardiography. CT can provide accurate measurements of myocardial thickness. Myocardial fibrosis can be demonstrated and quantified in delayed-enhancement images with substantial agreement with MRI [36-38]. CTA Coronary There is no relevant literature to support the use of CTA in the evaluation of HCM when ischemic cardiomyopathy has already been excluded. FDG-PET/CT Heart There is no relevant literature to support the use of FDG-PET/CT heart for the evaluation of HCM. MRI Chest There is no relevant literature to support the use of MRI chest for the evaluation of HCM. MRI Heart Function and Morphology MRI provides comprehensive information for the evaluation of HCM, including the morphology, location, distribution, and extent of hypertrophy and fibrosis [39]. MRI is superior to echocardiography in recognizing areas of segmental hypertrophy, which may be missed or underestimated with echocardiography, particularly the LV apex, the RV anterior free wall, and the LV inferoseptum [39,40]. RV hypertrophy is seen in a third of Nonischemic Myocardial Disease patients [40]. MRI is more accurate than echocardiography in quantifying the myocardial thickness, which is an important prognostic indicator for myectomy [39].